Thierry Huet

1.6k total citations
18 papers, 1.2k citations indexed

About

Thierry Huet is a scholar working on Molecular Biology, Genetics and Biotechnology. According to data from OpenAlex, Thierry Huet has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Biotechnology. Recurrent topics in Thierry Huet's work include Virus-based gene therapy research (7 papers), HIV Research and Treatment (6 papers) and Cancer Research and Treatments (6 papers). Thierry Huet is often cited by papers focused on Virus-based gene therapy research (7 papers), HIV Research and Treatment (6 papers) and Cancer Research and Treatments (6 papers). Thierry Huet collaborates with scholars based in France, Belgium and United States. Thierry Huet's co-authors include Georges E. Roelants, Andreas Meyerhans, Rémi Cheynier, Simon Wain–Hobson, Simon C.M. Kwok, John J. Sninsky, Maureen M. Goodenow, William Saurin, Rudi Pauwels and Erik De Clercq and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Thierry Huet

18 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Thierry Huet 713 482 423 296 203 18 1.2k
Ofir Israeli 380 0.5× 350 0.7× 600 1.4× 333 1.1× 152 0.7× 52 1.1k
Masashi Tatsumi 544 0.8× 474 1.0× 335 0.8× 148 0.5× 258 1.3× 63 1.1k
Anjali Joshi 830 1.2× 488 1.0× 556 1.3× 358 1.2× 433 2.1× 63 1.6k
P L Callahan 437 0.6× 496 1.0× 662 1.6× 332 1.1× 116 0.6× 9 1.3k
Atsushi Koito 1.1k 1.5× 574 1.2× 556 1.3× 294 1.0× 775 3.8× 43 1.8k
Dmitri N. Ivanov 469 0.7× 254 0.5× 545 1.3× 154 0.5× 274 1.3× 29 964
Yosuke Maeda 645 0.9× 582 1.2× 409 1.0× 205 0.7× 396 2.0× 68 1.3k
A.‐M. Aubertin 659 0.9× 407 0.8× 389 0.9× 386 1.3× 405 2.0× 56 1.2k
Fausto Titti 847 1.2× 242 0.5× 350 0.8× 326 1.1× 520 2.6× 49 1.1k
Thomas W. North 1.1k 1.6× 895 1.9× 504 1.2× 509 1.7× 187 0.9× 57 1.8k

Countries citing papers authored by Thierry Huet

Since Specialization
Citations

This map shows the geographic impact of Thierry Huet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Huet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Huet more than expected).

Fields of papers citing papers by Thierry Huet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Huet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Huet. The network helps show where Thierry Huet may publish in the future.

Co-authorship network of co-authors of Thierry Huet

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Huet. A scholar is included among the top collaborators of Thierry Huet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Huet. Thierry Huet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Médioni, Jacques, Luís Teixeira, Olivier Adotévi, et al.. (2021). Abstract CT021: INVAC-1, an optimized telomerase DNA vaccine in patients with advanced solid tumors: Final results of first-in-human phase I study. Cancer Research. 81(13_Supplement). CT021–CT021. 1 indexed citations
3.
Ruffié, Claude, Jessie Thalmensi, Valérie Najburg, et al.. (2019). Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice. Cancer Immunology Immunotherapy. 68(4). 533–544. 5 indexed citations
4.
Thalmensi, Jessie, Christelle Liard, Anna Kostrzak, et al.. (2019). A DNA telomerase vaccine for canine cancer immunotherapy. Oncotarget. 10(36). 3361–3372. 14 indexed citations
5.
Teixeira, Luís, Jacques Médioni, Ludovic Doucet, et al.. (2017). Results of a first-in-human phase I study of INVAC-1, an optimized plasmid DNA encoding an inactive form of human telomerase reverse transcriptase (hTERT), in patients with advanced solid tumors.. Journal of Clinical Oncology. 35(15_suppl). 3087–3087. 2 indexed citations
6.
Kostrzak, Anna, Vincent Caval, Jessie Thalmensi, et al.. (2016). APOBEC3A intratumoral DNA electroporation in mice. Gene Therapy. 24(2). 74–83. 2 indexed citations
7.
Thalmensi, Jessie, Christelle Liard, Anna Kostrzak, et al.. (2015). Anticancer DNA vaccine based on human telomerase reverse transcriptase generates a strong and specific T cell immune response. OncoImmunology. 5(3). e1083670–e1083670. 28 indexed citations
8.
Calvet, C., Jessie Thalmensi, Christelle Liard, et al.. (2014). Optimization of a gene electrotransfer procedure for efficient intradermal immunization with an hTERT-based DNA vaccine in mice. Molecular Therapy — Methods & Clinical Development. 1. 14045–14045. 21 indexed citations
9.
Huet, Thierry, Olivier Kerbarh, Dominique Schols, et al.. (2009). Long-Lasting Enfuvirtide Carrier Pentasaccharide Conjugates with Potent Anti-Human Immunodeficiency Virus Type 1 Activity. Antimicrobial Agents and Chemotherapy. 54(1). 134–142. 27 indexed citations
11.
Russell, Jeffery S., et al.. (2002). Inhibition of radiation-induced nuclear factor-kappaB activation by an anti-Ras single-chain antibody fragment: lack of involvement in radiosensitization.. PubMed. 62(8). 2318–26. 35 indexed citations
12.
Bougeret, Cécile, et al.. (2000). Cancer gene therapy mediated by CTS1, a p53 derivative: Advantage over wild-type p53 in growth inhibition of human tumors overexpressing MDM2. Cancer Gene Therapy. 7(5). 789–798. 13 indexed citations
13.
Russell, Jeffery S., Frederick F. Lang, Thierry Huet, et al.. (1999). Radiosensitization of human tumor cell lines induced by the adenovirus-mediated expression of an anti-Ras single-chain antibody fragment.. PubMed. 59(20). 5239–44. 32 indexed citations
14.
Poujade, Christèle, Michel Evers, Jean‐Christophe Carry, et al.. (1996). Betulinic Acid Derivatives:  A New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry. Journal of Medicinal Chemistry. 39(5). 1069–1083. 106 indexed citations
15.
Mayaux, J F, Anne Bousseau, Rudi Pauwels, et al.. (1994). Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells.. Proceedings of the National Academy of Sciences. 91(9). 3564–3568. 143 indexed citations
16.
Huet, Thierry, et al.. (1990). Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature. 345(6273). 356–359. 294 indexed citations
17.
Peeters, Martine, Cécile Honoré, Thierry Huet, et al.. (1989). Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon. AIDS. 3(10). 625–630. 176 indexed citations
18.
Goodenow, Maureen M., Thierry Huet, William Saurin, et al.. (1989). HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions.. PubMed. 2(4). 344–52. 277 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026